BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12565933)

  • 1. Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics.
    Dow RL; Schneider SR; Paight ES; Hank RF; Chiang P; Cornelius P; Lee E; Newsome WP; Swick AG; Spitzer J; Hargrove DM; Patterson TA; Pandit J; Chrunyk BA; LeMotte PK; Danley DE; Rosner MH; Ammirati MJ; Simons SP; Schulte GK; Tate BF; DaSilva-Jardine P
    Bioorg Med Chem Lett; 2003 Feb; 13(3):379-82. PubMed ID: 12565933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta.
    Hangeland JJ; Doweyko AM; Dejneka T; Friends TJ; Devasthale P; Mellström K; Sandberg J; Grynfarb M; Sack JS; Einspahr H; Färnegårdh M; Husman B; Ljunggren J; Koehler K; Sheppard C; Malm J; Ryono DE
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3549-53. PubMed ID: 15177471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyromimetics: a review of recent reports and patents (2004 - 2009).
    Hirano T; Kagechika H
    Expert Opin Ther Pat; 2010 Feb; 20(2):213-28. PubMed ID: 20100003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta.
    Li YL; Litten C; Koehler KF; Mellström K; Garg N; Garcia Collazo AM; Färnegård M; Grynfarb M; Husman B; Sandberg J; Malm J
    Bioorg Med Chem Lett; 2006 Feb; 16(4):884-6. PubMed ID: 16303304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective thyromimetics: tissue-selective thyroid hormone analogs.
    Scanlan TS; Yoshihara HA; Nguyen NH; Chiellini G
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):614-22. PubMed ID: 12825456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel heterocyclic thyromimetics. Part 2.
    Haning H; Mueller U; Schmidt G; Schmeck C; Voehringer V; Kretschmer A; Bischoff H
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3992-6. PubMed ID: 17499989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
    J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel heterocyclic thyromimetics.
    Haning H; Woltering M; Mueller U; Schmidt G; Schmeck C; Voehringer V; Kretschmer A; Pernerstorfer J
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1835-40. PubMed ID: 15780617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of high affinity thyromimetics containing a phenyl-naphthylene core.
    Hangeland JJ; Friends TJ; Doweyko AM; Mellström K; Sandberg J; Grynfarb M; Ryono DE
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4579-84. PubMed ID: 16099653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of halogen bonds in thyroid hormone receptor selectivity: pharmacophore-based 3D-QSSR studies.
    Valadares NF; Salum LB; Polikarpov I; Andricopulo AD; Garratt RC
    J Chem Inf Model; 2009 Nov; 49(11):2606-16. PubMed ID: 19863110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization and preliminary X-ray diffraction studies of isoform alpha1 of the human thyroid hormone receptor ligand-binding domain.
    Nunes FM; Aparicio R; Santos MA; Portugal RV; Dias SM; Neves FA; Simeoni LA; Baxter JD; Webb P; Polikarpov I
    Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1867-70. PubMed ID: 15388935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2D QSAR studies on thyroid hormone receptor ligands.
    Valadares NF; Castilho MS; Polikarpov I; Garratt RC
    Bioorg Med Chem; 2007 Jul; 15(13):4609-17. PubMed ID: 17467994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141.
    Garg N; Li YL; Garcia Collazo AM; Litten C; Ryono DE; Zhang M; Caringal Y; Brigance RP; Meng W; Washburn WN; Agback P; Mellström K; Rehnmark S; Rahimi-Ghadim M; Norin T; Grynfarb M; Sandberg J; Grover G; Malm J
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4131-4. PubMed ID: 17543524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease.
    Zhao M; Xie H; Shan H; Zheng Z; Li G; Li M; Hong L
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligands.
    Raval S; Raval P; Bandyopadhyay D; Soni K; Yevale D; Jogiya D; Modi H; Joharapurkar A; Gandhi N; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3919-24. PubMed ID: 18585912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activators of thyroid hormone receptors.
    Webb P
    Expert Opin Investig Drugs; 2004 May; 13(5):489-500. PubMed ID: 15155124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
    Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Nagano R; Matsuzawa A; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
    Bioorg Med Chem; 2012 Jun; 20(11):3622-34. PubMed ID: 22542282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis.
    Runfola M; Sestito S; Bellusci L; La Pietra V; D'Amore VM; Kowalik MA; Chiellini G; Gul S; Perra A; Columbano A; Marinelli L; Novellino E; Rapposelli S
    Eur J Med Chem; 2020 Feb; 188():112006. PubMed ID: 31931337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor.
    Borngraeber S; Budny MJ; Chiellini G; Cunha-Lima ST; Togashi M; Webb P; Baxter JD; Scanlan TS; Fletterick RJ
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15358-63. PubMed ID: 14673100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyromimetics: a journey from bench to bed-side.
    Tancevski I; Rudling M; Eller P
    Pharmacol Ther; 2011 Jul; 131(1):33-9. PubMed ID: 21504761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.